GET THE APP

..

Journal of Metabolic Syndrome

ISSN: 2167-0943

Open Access

Mark McCarty

Mark McCarty

Mark McCarty
Director
NutriGuard Research, USA

Biography

Mark McCarty has devoted his career to applied nutrition, and has also functioned as a biomedical theoretician, publishing over 230 speculative essays cited on MedLine, primarily in the journal Medical Hypotheses.  He is co-founder and Science Director of the nutraceutical company NutriGuard Research, was Research Director for Nutrition 21 during their development of supplemental selenium and chromium, has served as a consultant for several integrative cancer clinics as well as the Whitaker Wellness Institute, and is an editorial board member of Journal of Medicinal Food. He has a particular interest in the preventive health potential of whole-food plant-based diets, exercise strategies which achieve notable fat loss, and nutraceutical measures which address the complications of metabolic syndrome–most notably spirulina-derived phycocyanobilin, which can function as an inhibitor of NAPDH oxidase complexes. Cancer prevention is also a key interest. McCarty resides in San Diego.

Research Interest

Mark McCarty has a particular interest in the preventive health potential of whole-food plant-based diets, exercise strategies which achieve notable fat loss, and nutraceutical measures which address the complications of metabolic syndrome–most notably spirulina-derived phycocyanobilin, which can function as an inhibitor of NAPDH oxidase complexes. Cancer prevention is also a key interest.

Google Scholar citation report
Citations: 506

Journal of Metabolic Syndrome received 506 citations as per Google Scholar report

Journal of Metabolic Syndrome peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward